HyperGAM+: Began Phase I/II trials

Univax Biologics Inc. (UNVX), Rockville, Md. Genzyme Corp. (GENZ), Cambridge, Mass. Product: HyperGAM+ CF-specific polyclonal antibody Indication: Pseudomonas aeruginosa infection in cystic fibrosis ...